Reportlinker Adds Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain...(re 2.8: Lowest price guarantee offered b...),Health

Figure 3.9: Therapy areas with largest increase in incidents y-o-y (%), 2008 67

Figure 3.10: Key factors driving counterfeiting in pharmaceuticals 69

Figure 3.11: Increasing trend of counterfeiting, illegal diversion and theft of pharmaceuticals, 2002- 2008 70

Figure 3.12: Counterfeit access points in the drug distribution chain 87

Figure 4.13: Non-technical and technical anti-counterfeiting strategies used in the drug supply and distribution chain 107

Figure 4.14: Advantages & disadvantages of RFID & EPC anti-counterfeiting technologies 115

List of Tables

Table 1.1: Common pharmaceutical pricing controls 23

Table 1.2: European stakeholder support initiatives 46

Table 2.3: Key Provisions of the H.R.1 [108th] Medicare Prescription Drug, 51

Table 2.4: Key Provisions of the H.R.1 [108th] Medicare Prescription Drug, 52

Table 2.5: Popular online pharmacy brands, 2009 57

Table 2.6: Popular full service online pharmacies in the US 60

Table 2.7: Drug price savings offered by Canadian pharmacies in 2009 61

Table 3.8: Results of IMPACT-INTERPOL anti-counterfeit initiatives in developing countries 80

Table 3.9: Lifestyle drugs potentially targeted by counterfeiters 84

Table 3.10: Products susceptible to counterfeits in the US, 2004 85

Table 3.11: Authorized online pharmacies in the US 92

Table 4.12: Anti-counterfeiting technology types 109

Table 5.13: Key European Commission anti-counterfeiting proposals, 2008 124

Table 5.14: World Health Organization guidelines to combat drug counterfeiting 128

Table 5.15: EFPIA policy initiatives on parallel trade
'/>"/>